Natco Pharma reports around 3-fold jump in Q4 consolidated net profit

30 May 2017 Evaluate

Natco Pharma has reported results for fourth quarter and year ended March 31, 2017.    

The company has reported has posted over 2-fold jump in its net profit after tax at Rs 177.30 crore for the quarter ended March 31, 2017 as compared to Rs 69 crore for the same quarter in the previous year. Total income of the company increased by 41.09% at Rs 554.50 crore for quarter under review as compared to Rs 393 crore for the quarter ended March 31, 2016. 

On consolidated basis, the company has posted around 3-fold jump in its net profit at Rs 176.40 crore for the quarter ended March 31, 2017 as compared to Rs 63 crore for the same quarter in the previous year. Total income of the company increased by 46.20% at Rs 577.20 crore for quarter under review as compared to Rs 394.80 crore for the same quarter ended previous year. 

For the year ended March 31, 2017, the company has posted around 3-fold jump in its net profit at Rs 494.80 crore as compared to Rs 176.50 crore in FY16. Total income of company increased by 88.04% at Rs 2016 crore for year under review as compared to Rs 1072.10 crore for the year ended March 31, 2016.

For the year ended March 31, 2017, on the consolidated basis, the company has posted over 3-fold jump in its net profit at Rs 484.90 crore as compared to Rs 155.80 crore in the previous year. Total income of the company increased by 90.78% at Rs 2078.90 crore for year under review as compared to Rs 1089.70 crore for the year ended March 31, 2016.

Natco Pharma Share Price

887.30 -16.25 (-1.80%)
01-Jan-2026 13:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.90
Dr. Reddys Lab 1249.35
Cipla 1500.25
Zydus Lifesciences 913.15
Lupin 2100.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×